Billionaire Frost’s Opko to Buy Prolor in $480 Million Deal

Opko Health Inc. agreed to buy Israeli drugmaker Prolor Biotech Inc. for about $480 million to combine two companies that count U.S. pharmaceutical billionaire Phillip Frost as their largest shareholder.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.